ArticleVeterinary research2026
Stepwise evolution of tigecycline resistance in Enterococcus hirae through early IS1216E-mediated tet(L) amplification and subsequent rpsJ mutations.
Article in Veterinary research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Enterococcus spp. from food animals represent important reservoirs of antimicrobial resistance; however, the mechanisms underlying tigecycline resistance remain poorly understood. In this study, we investigated the genetic basis and evolutionary dynamics of tigecycline resistance in Enterococcus hirae. Among 118 Enterococcus isolates recovered from 150 swine-derived samples, E. hirae was the predominant species (68/118, 57.63%). Tigecycline resistance was identified in ten isolates (10/118, 8.47%), all belonging to a single E. hirae clone. Whole-genome sequencing of a representative isolate, EG2361, revealed three plasmids, among which pEG2361-2 harbored an IS1216E-associated multidrug resistance region capable of generating two circular translocatable units (TUs). TU1, carrying the promoter-variant tet(L) locus together with tet(M) and poxtA, underwent tandem amplification, leading to plasmid structural heterogeneity. Functional analyses demonstrated that tet(L) reduced tigecycline susceptibility, whereas enhanced resistance mainly associated with variation in the upstream promoter region rather than Tet(L) amino acid substitutions. Experimental evolution revealed a dynamic resistance trajectory. The initial increase in tigecycline resistance was associated with TU1 amplification and marked upregulation of tet(L) expression. Subsequently, tet(L) expression declined, whereas tigecycline minimum inhibitory concentrations (MICs) remained elevated and stable. Recurrent rpsJ mutations emerged independently across evolved lineages and were associated with high-level resistance. Together, these findings support a stepwise evolutionary model in which insertion sequence (IS)1216E-mediated amplification of the promoter-variant tet(L) locus drives rapid early adaptation, followed by the emergence of chromosomal rpsJ mutations associated with stable high-level resistance. This study expands current understanding of tigecycline resistance evolution in enterococci and highlights the interplay among mobile genetic elements, transcriptional regulation, and chromosomal adaptation in shaping antimicrobial resistance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.